HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Repare Therapeutics (NASDAQ:RPTX) and maintained a $25 price target on the stock.
November 20, 2023 | 11:40 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Repare Therapeutics and maintained a $25 price target.
The reiteration of a Buy rating and the maintenance of a $25 price target by a reputable analyst could lead to increased investor confidence and a potential short-term positive impact on RPTX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100